DEA rule seeks to make e-prescriptions more appealing to providers

05/3/2010 | Government Health IT magazine

A new Drug Enforcement Agency rule set to take effect next month could spur health IT adoption among providers by eliminating the requirement that they still use a paper-based system for controlled substances. Under the new rule, they will be allowed to use e-prescriptions for controlled substances. "Physicians will adopt e-prescribing much more rapidly when there is a singular work flow -- whether it's Lipitor or Valium," said Dr. John Halamka, Beth Israel Deaconess Medical Center CIO and Health IT Standards Committee co-chairman.

View Full Article in:

Government Health IT magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park